Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (Phase 1b); Protocol No. P07614.

Trial Profile

Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (Phase 1b); Protocol No. P07614.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Boceprevir (Primary)
  • Indications Hepatitis C
  • Focus Pharmacogenomic; Pharmacokinetics; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 05 Feb 2014 Status changed from suspended to discontinued, as per ClinicalTrials.gov record.
    • 28 May 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 09 Apr 2013 Planned End Date changed from 1 Nov 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top